- · 《中国慢性病预防与控制[10/30]
- · 《中国慢性病预防与控制[10/30]
- · 《中国慢性病预防与控制[10/30]
- · 《中国慢性病预防与控制[10/30]
- · 《中国慢性病预防与控制[10/30]
- · 《中国慢性病预防与控制[10/30]
- · 中国慢性病预防与控制版[10/30]
糖皮质激素治疗乙型肝炎病毒相关慢加急性肝衰(3)
作者:网站采编关键词:
摘要:[5] 余子琪,陈建勇.合理应用糖皮质激素治疗乙型肝炎病毒相关肝衰竭[J].国际消化病杂志,2017,37(6):366-368. [6] MA X,QIU consensus on the diagnosis and management of auto
[5] 余子琪,陈建勇.合理应用糖皮质激素治疗乙型肝炎病毒相关肝衰竭[J].国际消化病杂志,2017,37(6):366-368.
[6] MA X,QIU consensus on the diagnosis and management of autoimmune hepatitis(2015):Chinese Society of Hepatology,Chinese Society of Gastroenterology&Chinese Society of Infectious Diseases[J].J Dig Dis,2017,24(1):23-35.
[7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南(2010年修订版)[J].现代医药卫生,2011,18(5):167-170.
[8] SHI Y,YANG Y,HU Y,et liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults[J].Hepatology,2015,62(1):232-242.
[9] 张耿林,高志良.探索乙型肝炎相关慢加急性肝衰竭免疫调节治疗的新思路[J].中国病毒病杂志,2019,9(1):1-5.
[10]叶一农,高志良.乙型肝炎肝衰竭发生机制中的三重打击[J].传染病信息,2009,22(5):638-640.
[11]ZHENG YB,HUANG ZL,WU ZB,et changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure:a retrospective cohort study[J].Int J Med Sci,2013,10(12):1658-1664.
[12]FUJIWARA K,YASUI S,YONEMITSU Y,et of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B[J].J Gastroenterol,2008,43(9):711-719.
[13]SUGIYAMA A,SATO A,SHIMIZU H,et lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats[J].J Vet Med Sci,2010,72(2):173-180.
[14]NOVELLI G,ANNESINI MC,MORABITO V,et level modifications:molecular adsorbent recirculating system versus standard medical therapy[J].Transplant Proc,2009,41(4):1243-1248.
[15]李梦东,聂青和.糖皮质激素治疗重型肝炎的临床及实验研究[J].实用肝脏病杂志,2005,8(1):1-6.
[16]GAO L,WANG JF,XIANG M,et of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure[J].Dig Dis Sci,2011,56(9):2605-2612.
[17]ZHAO Q,WU CS,FANG Y,et regulates NLRP3 in acute-on-chronic hepatitis B liver failure[J].Int J Med Sci,2019,16(3):461-469.
[18]RUTHERFORD AE,HYNAN LS,BORGES CB,et al.Serum apoptosis markers in acute liver failure:a pilot study[J].Clin Gastroenterol Hepatol,2007,5(12):1477-1483.
[19]JIN X,ZIMMERS TA,PEREZ EA,et effects of short and long-term interleukin-6 exposure on liver injury and repair[J].Hepatology,2006,43(3):474-484.
[20]ALAM A,SUEN KC,MA liver failure:recent update[J].J Biomed Res,2017,31(3):1-18.
[21]GREULICH F,HEMMER MC,ROLLINS DA,et al.There goes the neighborhood:Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor[J].Steroids,2016,114:7-15.
[22]李晶,王鲁文,龚作炯.糖皮质激素治疗重型肝炎有效性及安全性的Meta分析[J].实用肝脏病杂志,2011,14(2):121-123,134.
[23]ZHANG XQ,JIANG L,YOU JP,et of short-term dexamethasone therapy in acute-on-chronic pre-liver failure[J].Hepatol Res,2011,41(1):46-53.
[24]孟庆华.糖皮质激素治疗肝衰竭的时机把握[J].临床肝胆病杂志,2017,33(9):1683-1686.
[25]杨晓鲲,徐贵森.糖皮质激素治疗乙型肝炎病毒相关性肝衰竭疗效的Meta分析[J].解放军医学杂志,2013,38(7):581-585.
[26]BO Q,LING Z,TANGMING of low-dose glucocorticoids in treatment of HBV-related acute-on-chronic liver failure[J].J Clin Hepatol,2016,32(7):1300-1304.
[27]梁政,刘海燕,邱芳英.小剂量糖皮质激素治疗HBV相关慢加急性肝衰竭的效果分析[J].中国实用医药,2017,12(33):89-90.
[28]郑锦辉,孙蕾,郑晓华.小剂量糖皮质激素治疗乙肝相关慢加急性肝衰竭早期疗效观察[J].山东医药,2014,54(1):51-53.
[29]JAN-HENDRIK B,MAURA D,LUTH STEFAN,et glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure[J].World J Gastroenterol,2015,21(7):2214-2219.
[30]HE B,ZHANG Y,LU,MH,et s can increase the survival rate of patients with severe viral hepatitis B:a meta-analysis[J].Eur J Gastroenterol Hepatol,2013,25(8):926-934.
[31]张竟臻.胸腺肽α1联合糖皮质激素对乙肝相关性慢加急性肝衰竭患者PTA 及TBiL 的影响[J].医学理论与实践,2017,30(15):2251-2252.
[32]王鹏,梁利民,郑吉顺,等.血浆置换术联合糖皮质激素应用对乙型肝炎病毒所致早期肝衰竭患者的临床观察[J].医学理论与实践,2017,30(12):1733-1735.
[33]龙云,刘云华,邓兰,等.糖皮质激素递减疗法治疗乙型肝炎肝衰竭患者的疗效及安全性分析[J].实用肝脏病杂志,2016,19(3):297-300.
文章来源:《中国慢性病预防与控制》 网址: http://www.zgmxbyfykz.cn/qikandaodu/2021/0512/918.html